INNOVEX CO-INVEST FUND, L.P. - 27 Feb 2026 Form 4 Insider Report for Innovex International, Inc. (INVX)

Signature
INNOVEX CO-INVEST FUND, L.P., By: Innovex Co-Invest Fund GP, L.P., its general partner, By: Innovex Co-Invest Associates, LLC, its general partner, By: /s/ Jason Turowsky, Name: Jason Turowsky, Title: Partner
Issuer symbol
INVX
Transactions as of
27 Feb 2026
Net transactions value
-$162,609,971
Form type
4
Filing time
27 Feb 2026, 20:14:23 UTC
Previous filing
10 Sep 2024

Reporting Owners (9)

Name Relationship Address Signature Signature date CIK
INNOVEX CO-INVEST FUND, L.P. Director, 10%+ Owner 1021 MAIN STREET, SUITE 1100, HOUSTON INNOVEX CO-INVEST FUND, L.P., By: Innovex Co-Invest Fund GP, L.P., its general partner, By: Innovex Co-Invest Associates, LLC, its general partner, By: /s/ Jason Turowsky, Name: Jason Turowsky, Title: Partner 27 Feb 2026 0001777512
Innovex Co-Invest Fund GP, L.P. Director, 10%+ Owner 4400 POST OAK STREET, SUITE 2760, HOUSTON INNOVEX CO-INVEST FUND GP, L.P., By: Innovex Co-Invest Associates, LLC, its general partner, By: /s/ Jason Turowsky, Name: Jason Turowsky, Title: Partner 27 Feb 2026 0002026025
Interval Capital Associates II, LLC Director, 10%+ Owner 4400 POST OAK PARKWAY, SUITE 2760, HOUSTON INTERVALE CAPITAL ASSOCIATES II, LLC, By: /s/ Jason Turowsky, Name: Jason Turowsky, Title: Partner 27 Feb 2026 0002026023
Intervale Capital Associates III, LLC Director, 10%+ Owner 4400 POST OAK PARKWAY, SUITE 2760, HOUSTON INTERVALE CAPITAL ASSOCIATES III, LLC, By: /s/ Jason Turowsky, Name: Jason Turowsky, Title: Partner 27 Feb 2026 0002026022
Intervale Capital Fund II, L.P. Director, 10%+ Owner 4400 POST OAK PARKWAY, SUITE 2760, HOUSTON INTERVALE CAPITAL FUND II, L.P., By: Intervale Capital GP II, L.P., its general partner, By: Intervale Capital Associates II, LLC, its general partner, By: /s/ Jason Turowsky, Name: Jason Turowsky, Title: Partner 27 Feb 2026 0001538026
Intervale Capital Fund II-A, L.P. Director, 10%+ Owner 4400 POST OAK PARKWAY, SUITE 2760, HOUSTON INTERVALE CAPITAL FUND II-A, L.P., By Intervale Capital GP II, L.P., its general partner, By: Intervale Capital Associates II, LLC, its general partner, By: /s/ Jason Turowsky, Name: Jason Turowsky, Title: Partner 27 Feb 2026 0001549399
Intervale Capital Fund III, L.P. Director, 10%+ Owner 4400 POST OAK PARKWAY, SUITE 2760, HOUSTON INTERVALE CAPITAL FUND III, L.P., By: Intervale Capital GP III, L.P., its general partner, By: Intervale Capital Associates III, LLC, its general partner, By: /s/ Jason Turowsky, Name: Jason Turowsky, Title: Partner 27 Feb 2026 0001600328
Intervale Capital GP II, L.P. Director, 10%+ Owner 4400 POST OAK PARKWAY, SUITE 2760, HOUSTON INTERVALE CAPITAL GP II, L.P., By: Intervale Capital Associates II, LLC, its general partner, By: /s/ Jason Turowsky, Name: Jason Turowsky, Title: Partner 27 Feb 2026 0002026024
Intervale Capital GP III, L.P. Director, 10%+ Owner 4400 POST OAK PARKWAY, SUITE 2760, HOUSTON INTERVALE CAPITAL GP III, L.P., By: Intervale Capital Associates III, LLC, its general partner, By: /s/ Jason Turowsky, Name: Jason Turowsky, Title: Partner 27 Feb 2026 0002026021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction INVX Common Stock Sale $120,552,553 -4,902,244 -23% $24.59 16,871,374 27 Feb 2026 By Amberjack Capital Fund II, L.P. F1, F7, F8, F9, F10
transaction INVX Common Stock Sale $28,148,063 -1,144,635 -23% $24.59 3,939,330 27 Feb 2026 By Innovex Co-Invest Fund II, L.P. F2, F7, F8, F9, F10
transaction INVX Common Stock Sale $6,671,103 -271,279 -23% $24.59 933,624 27 Feb 2026 By Innovex Co-Invest Fund, L.P. F3, F7, F8, F9, F10
transaction INVX Common Stock Sale $5,754,586 -234,009 -23% $24.59 805,355 27 Feb 2026 By Intervale Capital Fund II, L.P. F4, F7, F8, F9, F10
transaction INVX Common Stock Sale $2,853 -116 -23% $24.59 399 27 Feb 2026 By Intervale Capital Fund II-A, L.P. F5, F7, F8, F9, F10
transaction INVX Common Stock Sale $1,480,814 -60,217 -23% $24.59 207,240 27 Feb 2026 By Intervale Capital Fund III, L.P. F6, F7, F8, F9, F10
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Consists of shares of common stock, par value $0.01 per share, of the Issuer held directly by Amberjack Capital Fund II, L.P. ("Common Stock") that were sold in an underwritten secondary offering (the "Offering") at a price to the public of $25.75 per share. Amberjack Capital Fund II, L.P. received $24.59125 per share of Common Stock sold in the Offering, which is the public offering price less certain underwriting discounts.
F2 Consists of shares of Common Stock held directly by Innovex Co-Invest Fund II, L.P. that were sold in the Offering at a price to the public of $25.75 per share. Innovex Co-Invest Fund II, L.P. received $24.59125 per share of Common Stock sold in the Offering, which is the public offering price less certain underwriting discounts.
F3 Consists of shares of Common Stock held directly by Innovex Co-Invest Fund, L.P. that were sold in the Offering at a price to the public of $25.75 per share. Innovex Co-Invest Fund, L.P. received $24.59125 per share of Common Stock sold in the Offering, which is the public offering price less certain underwriting discounts.
F4 Consists of shares of Common Stock held directly by Intervale Capital Fund II, L.P. that were sold in the Offering at a price to the public of $25.75 per share. Intervale Capital Fund II, L.P. received $24.59125 per share of Common Stock sold in the Offering, which is the public offering price less certain underwriting discounts.
F5 Consists of shares of Common Stock held directly by Intervale Capital Fund II-A, L.P. that were sold in the Offering at a price to the public of $25.75 per share. Intervale Capital Fund II-A, L.P. received $24.59125 per share of Common Stock sold in the Offering, which is the public offering price less certain underwriting discounts.
F6 Consists of shares of Common Stock held directly by Intervale Capital Fund III, L.P. that were sold in the Offering at a price to the public of $25.75 per share. Intervale Capital Fund III, L.P. received $24.59125 per share of Common Stock sold in the Offering, which is the public offering price less certain underwriting discounts.
F7 The general partner of (i) Amberjack Capital Fund II, L.P. is Amberjack Capital GP II, L.P., and the general partner of such general partner is Amberjack Capital Associates II, LLC, (ii) Innovex Co-Invest Fund II, L.P. is Innovex Co-Invest Fund II GP, L.P., and the general partner of such general partner is Innovex Co-Invest Associates, LLC, (iii) Innovex Co-Invest Fund, L.P. is Innovex Co-Invest Fund GP, L.P., and the general partner of such general partner is Innovex Co-Invest Associates, LLC, (iv) Intervale Capital Fund II, L.P. is Intervale Capital GP II, L.P., and the general partner of such general partner is Intervale Capital Associates II, LLC, (v) Intervale Capital Fund II-A, L.P. is Intervale Capital GP II, L.P., and the general partner of such general partner is Intervale Capital Associates II, LLC, and (vi) Intervale Capital Fund III, L.P. is Intervale Capital GP III, L.P., and the general partner of such general partner is Intervale Capital Associates III, LLC.
F8 (Continued from footnote 7) Funds affiliated with Amberjack Capital Partners, L.P. ("Amberjack Capital Partners") are referred to as the "Amberjack Funds".
F9 By virtue of their relationships, the foregoing general partners control all voting and dispositive power over the reported shares held by such Amberjack Fund and therefore may be deemed to be the beneficial owner of such shares. The sole member of Amberjack Capital Associates II, LLC, Innovex Co-Invest Associates, LLC, Intervale Capital Associates II, LLC and Intervale Capital Associates III, LLC is Amberjack Capital Partners, and the general partner of Amberjack Capital Partners is Amberjack Management, LLC ("Amberjack Management"). By virtue of their relationships, Amberjack Capital Partners and Amberjack Management control all voting and dispositive power over the reported shares held by all the Amberjack Funds and therefore may be deemed to be the beneficial owner of such shares. Jason Turowsky is managing partner of Amberjack Management.
F10 (Continued from footnote 9) Mr. Turowsky disclaims beneficial ownership of such securities in excess of his pecuniary interests in the securities.

Remarks:

This Form 4 is the second of two Forms 4 being filed relating to the same event. The Form 4 has been split into two filings because there are more than 10 Reporting Persons in total, and the SEC's EDGAR filing system limits a single Form 4 to a maximum of 10 Reporting Persons. The first of two Forms 4 was filed by the designated filer Amberjack Capital Partners, L.P.